America’s Food and Drug Administration approved a medication produced by Eli Lilly, a pharmaceutical firm, for weight-loss use. The injectable, called Zepbound, is part of a new generation of obesity drugs, and has the same active ingredient as Mounjaro, which is already approved to treat diabetes. It will compete against Novo Nordisk’s Wegovy, the weight-loss version of Ozempic.
Buy RMD now and get great upside returns in a year or two, page-5
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$33.06 |
Change
0.395(1.21%) |
Mkt cap ! $21.21B | |||
| Open | High | Low | Value | Volume |
| $32.95 | $33.23 | $32.89 | $15.34M | 464.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 945 | $33.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $33.07 | 622 | 7 |
View Market Depth
| Last trade - 14.44pm 12/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |